Loading...
Loading...
QTNT| Name | Value |
|---|---|
| Revenues | 9.1M |
| Cost of Revenue | 5.3M |
| Gross Profit | 3.8M |
| Operating Expense | 25.8M |
| Operating I/L | -22.0M |
| Other Income/Expense | -2.4M |
| Interest Income | 0.0M |
| Pretax | -24.4M |
| Income Tax Expense | -0.0M |
| Net Income/Loss | -24.4M |
Quotient Limited is a commercial-stage diagnostics company that develops, manufactures, and sells products for the global transfusion diagnostics market. The company's primary focus is on its proprietary technology platform, MosaiQ, which offers tests for immunohematology, serological disease screening, and molecular disease screening. Its product line includes conventional reagent products for blood grouping, whole blood control products, and ancillary products to support blood grouping. Additionally, Quotient Limited offers various microarray tests for serological and molecular disease screening, as well as specific tests for autoimmune diseases and COVID-19. The company's customers include hospitals, donor collection agencies, independent testing laboratories, original equipment manufacturers, and blood banking operations.
